Introduction {#Sec1}
============

Liver transplantation has become a widely accepted therapy for the management of the complications of cirrhosis and liver failure.

Objectives {#Sec2}
==========

To analyze the patients undergoing the Liver transplant Recipients and the factors influencing the outcome of the patients at our tertiary care hospital.

Methods {#Sec3}
=======

The patients underwent liver transplantation recepients between May 2014 to Jan 2015 were analysed. The data was collected from patient records after ethics committee approval. The data captured were Age,sex, ICU and hospital length of stay, bilirubin, albumin, INR, creatinine, intubation days, readmission,cold ischemia, warm ischemia, portal vein thrombosis, SGOT, SGPT, Vasopressors use, APACHE II, SOFA Score, MELD Score, arterial anatomy, graft complications, hospital and 60day mortality, readmissions, hospital acquired infections are monitored.

Results {#Sec4}
=======

The total number of patients enrolled are 34. See tables [1](#Tab1){ref-type="table"}, [2](#Tab2){ref-type="table"} and [3](#Tab3){ref-type="table"}Table 1Demographic data of the transplant receipients.VariableMean n (%)Age in years49.5Sex Male27 (79.41)Cause of liver transplant (Alcohol cirrhosis)20 (58.82)APACHE II at admission12.59SOFA at admission7MELD Score20.35No Comorbidities26 (76%)INR2.6Total bilirubin mg/dl4.51Table 2Outcome data of transplant patients.VariableMeanICU length of stay in days4.85Hospital length of stay in days15.18Cold ischemia time in minutes243Warm ischemia time in minutes45.06Ventilator days0.85Blood products received (PRBC)9.41Albumin mg/dl2.91Creatinine mg/dl1.23Max SGOT U/L / Max SGPT U/L / Lowest Platelets 10/mm1227 / 592 / 42.3Table 3Mortality and other outcomes of the patients.VariableNumberPercentageGraft Whole / partial26 / 876.5 / 23.5Mortality12.94Arterial anatomy abnormality411.76Renal Replacement therapy12.94Vasopressors use514.71Readmission25.89Portal Vein Thrombosis25.89

The hospital mortality rate in our study is 2.94% (one patient).

All the patients are ABO compatable, 2 patients had early graft rejection of which one patient liver functions has completely recovered and the other had not fully recovered. The hospital acquired infections are nil in these patients.

26 (76.47%) liver donors are brain death patients. 5 (14.71%) receipient patients are HCV positive. The factors increasing the the mortality are Increased ICU and hospital length of stay, reintubation, readmission and renal replacement therapy.

The statistically significant factors which increase the ICU length of stay are increased Bilurubin, decreased Albumin, increased ventilator days, increased Cold Ischemia and Warm Ischemia time, use of Vasopressors, lowest Platelets and raised INR.

The statistically significant factors which increase the Hospital length of stay are decreased Albumin, increased ventilator days, reintubation, use of Vasopressors, readmission and lower platelets. The 60 day mortality is similar to hospital mortality.

Conclusions {#Sec5}
===========

The patients undergoing the Liver transplant Recipients had good outcomes with less mortality and is comparable to the best centres in the world.

Hospital acquired infections are nil in these patients.

We need larger number to analyse the patients.
